uniQure (QURE) Raw Materials (2022 - 2024)

uniQure (QURE) recorded quarterly Raw Materials of $6.3 million in Q1 2024, down 11.54% quarter-over-quarter from $7.2 million in Q4 2023.

uniQure (QURE) Raw Materials (2022 - 2024) Analysis & Trends

uniQure's Raw Materials history runs 3 years deep, the most recent figure standing at $6.3 million for Q1 2024.

  • In Q1 2024, Raw Materials changed N/A year-over-year to $6.3 million; the TTM figure through Mar 2024 stood at $6.3 million (changed N/A YoY), while the FY2023 annual figure was $7.2 million, up 99.69% from the prior year.
  • Raw Materials was $6.3 million for Q1 2024 at uniQure, down from $7.2 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $7.4 million in Q3 2023 to a low of $1.4 million in Q3 2022.
  • Historically, Raw Materials has averaged $5.3 million across 3 years, with a median of $6.2 million in 2023.
  • Biggest YoY gain for Raw Materials was 413.2% in 2023; the steepest drop was 99.69% in 2023.
  • A 3-year view of Raw Materials shows it stood at $3.6 million in 2022, then soared by 99.69% to $7.2 million in 2023, then slipped by 11.54% to $6.3 million in 2024.
  • The last three Raw Materials figures came in at $6.3 million (Q1 2024), $7.2 million (Q4 2023), and $7.4 million (Q3 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 uniQure 2.88 Bn 2.88 Bn 3.34 Mn

Historic Data

Download Data
DateValue
Mar 31, 2024 6.33 Mn
Dec 31, 2023 7.16 Mn
Sep 30, 2023 7.43 Mn
Jun 30, 2023 6.01 Mn
Dec 31, 2022 3.58 Mn
Sep 30, 2022 1.45 Mn